| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,385 | 1,490 | 17:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.11. | Mentice AB Q3 Loss Rises | 1 | RTTNews | ||
| 10.11. | Mentice AB: Mentice publishes its interim report for the period July-September 2026 | 136 | GlobeNewswire (Europe) | STRONG ORDER INTAKE, PROFITABILITY IMPACTED BY ONE-OFFS
THIRD QUARTER 2026 (JUL-SEP)Net sales totaled 72.6 (70.6) MSEK. Organic growth was 0.8%, while growth amounted to 2.9% after FX effects.Order... ► Artikel lesen | |
| MENTICE Aktie jetzt für 0€ handeln | |||||
| 23.07. | Mentice AB: Mentice Growth Trajectory Continues In Q2 2026 | 357 | GlobeNewswire (Europe) | SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2026 (APR - JUN)On June 29, Mentice announced the receipt of two orders with a total value of USD 2.4M from one of the top 20 global MedTech companies within... ► Artikel lesen | |
| 29.06. | Mentice AB: Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease | 541 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided therapies, today announced the receipt of two orders in total value of $2.4M from one of the world's top 20 medical... ► Artikel lesen | |
| 01.06. | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | 1.042 | GlobeNewswire (Europe) | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| 07.05. | Mentice AB: Interim Report Jan-mar 2026 | 347 | GlobeNewswire (Europe) | CONTINUED MOMENTUM AND STRONG ORGANIC GROWTH
Significant events during the FIRST quarter 2026 (JAN - MAR)Order intake and revenues increased significantly during the quarter and Order Intake amounted... ► Artikel lesen | |
| 23.03. | Mentice AB: Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group | 272 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg, Sweden - Mentice today announced the appointment of Rick van Veen as Chief Financial Officer, effective July 1, 2026. Rick brings extensive experience in financial management... ► Artikel lesen | |
| 26.02. | Mentice AB: Communique from extraordinary shareholders' meeting in Mentice AB | 298 | GlobeNewswire (Europe) | An extraordinary shareholders' meeting was held in Mentice AB ("the Company") on February 26, 2026. Below follows a summary of the resolutions made at the meeting.
Resolution on the number of board... ► Artikel lesen | |
| 26.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2025 | 307 | GlobeNewswire (Europe) | STRONG ORGANIC GROWTH AND RESULT IMPROVEMENT DESPITE CURRENCY HEADWINDS
SIGNIFICANT EVENTS DURING THE FOURTH QUARTER 2025 (OCT - DEC)Order intake increased significantly during the quarter and amounted... ► Artikel lesen | |
| 08.12.25 | Bure Equity AB: Bure divests holding in Mentice | 521 | GlobeNewswire (Europe) | Bure Equity AB (publ) ("Bure") has signed an agreement to divest 4,037,824 shares in Mentice AB (publ), listed on Nasdaq First North Growth Market.
The buyer is Gulf Offshore Limited, a company controlled... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,560 | -1,29 % | Eckert & Ziegler Q3 review: a stronger dose of earnings: EUZ's Q3 earnings recovery provides a firmer base for year-end ... | Eckert & Ziegler's Q3 delivered a clear return to growth in adj. EBIT. Group sales increased 6% yoy to € 79.6m (eCons: € 79.3m), with adj. EBIT rising 25% yoy to € 19.3m (eCons: € 18.8m). The margin... ► Artikel lesen | |
| PENUMBRA | 290,60 | -0,34 % | Penumbra, Inc.: Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT) | BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and... ► Artikel lesen | |
| FRESENIUS | 51,55 | -0,44 % | Fresenius gewinnt eine neue Wachstumsstory | Fresenius hat den schwierigen Teil seiner Neuaufstellung offenbar weitgehend hinter sich gelassen. Der Gesundheitskonzern steigert seine Profitabilität, reduziert die finanzielle Belastung und hebt... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,760 | +2,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,230 | -1,35 % | Siemens Healthineers Aktie: Zwischen Übergangsjahr und Kursfantasie | Die Analysten sind sich nach den jüngsten Quartalszahlen von Siemens Healthineers uneinig über die weiteren Perspektiven der Aktie. Während Jefferies nach der Erholung im Geschäft mit medizinischer... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | -0,53 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| HEARTFLOW | 45,630 | +2,19 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| LIFESTANCE HEALTH GROUP | 13,650 | +2,32 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,330 | +2,59 % | Privia Health Group, Inc.: Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program | ||
| GERRESHEIMER | 32,060 | -2,85 % | Gerresheimer: Was Anleger vor dem Jahresfinale prüfen sollten | ||
| PROGYNY | 35,920 | +1,33 % | Rekorde bei Familienplanung: Progyny glänzt mit blitzsauberer Bilanz und massiven Rückkäufen | Hier an der Wall Street in New York wird oft das schnelle Geld gesucht. Doch die wahren Börsenperlen findet man häufig in lukrativen Nischen, in denen ein Unternehmen zum unverzichtbaren Marktführer... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,835 | +0,33 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| UNITEDHEALTH | 314,80 | +4,58 % | AKTIEN IM FOKUS: US-Krankenversicherer geraten weiter unter Druck | NEW YORK (dpa-AFX) - Die Aktien von US-Krankenversicherern sind am Mittwoch weiter unter Druck geraten. Als Schlusslicht im Dow Jones Industrial büßten Unitedhealth 8,6 Prozent ein, womit die Aktien... ► Artikel lesen | |
| DRAEGERWERK | 117,20 | +1,21 % | DRÄGERWERK setzt Ziele hoch | Im kommenden Jahr will man Umsatz und Profitabilität deutlich steigern. Auf dem heutigen Kapitalmarkttag von DRÄGERWERK erklärte das Unternehmen, dass der Erlös 2030 dann rund 4,5 Mrd. Euro erreichen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 6,605 | +1,62 % | Alignment Healthcare falls 9% amid weakness in Medicare Advantage stocks |